Extensive experience in the Finnish pharmaceutical market
Tailor-made solutions for your business needs
The widest service range for support of entering the market
Studies based on Real-World Evidence (RWE)
Real-World Data (RWD) refers to health data that can be used, for instance, to show the value of treatments or technologies for patients, health service providers or society (RWE).
Our subsidiary Medaffcon has the most experience in real-world data analytics and utilisation in Finland.
Critical pathway and stakeholder surveys
The survey provides an overview of the clinical practices related to the treatment of diseases and the decision-making processes of various health care units in Finland.
Our subsidiary Medaffcon combines real-world register or biobank data with clinical practice projects and conducts comprehensive critical pathway and stakeholder surveys.
Health economic modelling
Health economic modelling forms an important part of health economic analyses and is a key tool for those responsible for making decisions on the use of health resources.
Our subsidiary Medaffcon is implementing modelling projects that range from locating global models to building a complete model from scratch.;
Price and reimbursement applications
The presence of an outpatient medicine on the market requires that the product be reimbursed to the patient from health insurance. The aim is to make the medicinal product available to patients as quickly and broadly as possible.
Our subsidiary Medaffcon offers assistance at all stages of the price and reimbursement process.
Confidential price agreements, such as risk-sharing agreements, have become more common in hospital pharmaceuticals, while conditional reimbursement decisions are becoming established in the price and reimbursement processes of community care medicines.
By combining our subsidiary Medaffcon's extensive expertise and the Tamro LINK service, we offer a comprehensive solution for implementing risk-sharing models.
The Tamro LINK service provides a tool for implementing value-based pricing models for hospital medicines. The e-service facilitates the management, monitoring and possible calculation of refunds of pricing agreements between pharmaceutical companies and hospitals.
The service is open to all pharmaceutical companies and not tied to the wholesaler used by the pharmaceutical company. The national service is operational in all hospitals.
An expert from our subsidiary Medaffcon acts as a temporary resource in your community or company, flexibly implementing Market Access projects to meet your needs. The scope, duration and content of the commission may vary from projects that last for a few weeks to multi-year collaboration.
Our subsidiary Medaffcon offers bespoke training packages tailored to the customer’s particular needs. For instance, the following packages are offered:
- Utilising Real-World Evidence (RWE) workshop
- Market Access Workshop
- The Rules of Pharmaceutical Marketing training